Close Menu

NEW YORK – Qiagen is developing a pair of molecular assays to detect the 2019 novel coronavirus (2019-nCoV) from nasal swabs of symptomatic patients, a company executive said this week.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.